The type 1 human immunodeficiency virus Tat protein is a powerful transcriptional activator when bound to an RNA structure (TAR) present at the extreme 5' terminus of viral mRNA. Since transcriptional activation requires binding of Tat to RNA, it has been suggested that Tat enhances initiation or elongation through a direct interaction with cellular transcription factors. Here we show through protein fusion experiments that the previously identified cellular Tat binding protein, TBP-1, although unable to bind DNA, is a strong transcriptional activator when brought into proximity of several promoter elements. Transcriptional activity depends upon the integrity of at least two highly conserved domains: one resembling a nucleotide-binding motif and the other motif common to proteins with helicase activity. Our studies further reveal that TBP-1 represents one member of a large, highly conserved gene family that encodes proteins demonstrating strong amino acid conservation across species. Finally, we identified a second family member that, although 77% similar to TBP-1, does not activate transcription from the promoters examined. This finding, together with the observation that TBP-1 does not activate each promoter examined, suggests that this gene family may encode promoter-specific transcriptional activators.
The type 1 human immunodeficiency virus (HIV) Tat protein (1, 2) represents one of two viral regulatory proteins essential for virus replication (3) . Although the mechanism of Tat function has been controversial, the establishment of a cellfree transactivation system clearly demonstrates that Tat is a potent transcriptional activator (4) (5) (6) (7) . The in vitro results further suggest that Tat functions at the level of elongation (4, 5) .
The mechanism of Tat function appears to differ from that of other transcriptional activators. For example, Tat elicits its effect after interaction (6, 8) with an RNA structure [referred to as TAR (9) ] present at the extreme 5' terminus of each viral transcript. The TAR sequence has been shown to form a stem-loop structure containing a bulge in the stem. Sequences within the loop and bulge are essential for Tat function in vivo (8, (10) (11) (12) , although in vitro analysis suggests that the bulge sequences and not the loop are required for interaction with Tat (6, 8) . These findings imply that cellular factors that associate with loop sequences may be essential for the transactivation response. Indeed several studies have identified specific cellular factors that associate with the loop sequence (13) (14) (15) (16) .
The ability to elicit transactivation without direct interaction with DNA suggests that Tat might associate with cellular factors, which in turn interact with DNA or promoter-bound transcription factors. Using purified Tat protein to screen a Agtll cDNA library, we previously described the identification of a cDNA that encodes a protein designated Tat binding protein 1 (TBP-1), which associates with Tat (17) . More recent reports suggest that TBP-1 represents one member of a large highly conserved gene family. One human homolog, designated MSS-1, shares 42% sequence identity with TBP-1 and has been shown to enhance Tat-mediated transactivation (18) . MSS-1 was originally identified by transcomplementation of a yeast Sgv-1 mutation, which encodes a CDC28/ CDC2 related kinase that appears to regulate G1 cyclins (19) . A second homolog termed SUG-1, or TBP-y, identified in the yeast Saccharomyces cerevisiae also shares considerable homology with TBP-1 (20, 21) . A mutant form of SUG-1, which is an essential gene in yeast, was isolated as a supressor in an assay to determine whether the yeast transcriptional activator GAL4 can function when its C-terminal activation domain is deleted. The diverse manner in which each of these genes was identified does not provide a clear picture relating to their function.
To gain further insight toward the function of TBP-1 and the related family members, a series of protein fusion experiments were performed. A fusion protein of TBP-1 with the DNA binding domain of the yeast transcriptional activator GAL4 demonstrated strong transcriptional activity on several promoters bearing the GAL4 DNA-binding site. Transcriptional activity was abolished following mutation of a putative nucleotide-binding site and a helicase motif. Using a genetic assay in yeast, we observed that TBP-1 can heterodimerize with at least one related human homolog. Surprisingly, the dimerization domain lies outside of the area sharing strong sequence conservation. The ability of TBP-1 to activate only a subset of the promoters examined and the inability ofa highly conserved human homolog to activate any of the promoters tested suggest that this gene family may encode a class of promoterspecific transcriptional activators.
MATERIALS AND METHODS
Plasmid Constructions. The plasmids pGAL-TBP-1 and pGAL-TBP-7 were prepared as follows: the full-length genes encoding the TBP-1 and TBP-7 cDNAs were amplified by PCR and ligated into the EcoRI-Xba I site of the pSG424 mammalian expression vector (22) to create a fusion to the DNA-binding domain of the yeast transcriptional activator protein GAL4 (amino acids 1-147).
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The GAL-TBPAGKT, GAL-TBP/K(235)-H, and GAL-TBP/D(285)-A mutants were prepared in two-step PCR reactions. Epitope-tagged TBP-1 (HATBP-1), TBP-7 (HATBP-7), and TBP1AGKT (HATBP-1lAGKT) genes were constructed by PCR, using a 5' primer encoding the amino acid sequence MYPYDVPDYA corresponding to the influenza virus hemagglutinin (HA) protein (23) and cloned into the HindIII-Xba I site of the eukaryotic expression vector soC-MVIN (24) .
Yeast Plasmids. pGAL-TBP-1, pGAL-TBP-7, and pGAL4-(1-147) were subcloned out of the pSG424-based vectors and inserted into the HindIII-Xba I sites preceding the ADHI promoter of pVL100 (25) . Deletions of pGAL-TBP-1 were created by PCR to generate the set of pYGAL-TBP plasmids. For herpes simplex viral protein 16 (VP16) fusions, the C-terminal 78 amino acids of VP16 were isolated by PCR from pMSVP16 (26) and subcloned into the HindIII-Pvu II sites preceding the ADHJ promoter present in pVU100 (25) to create pYVP16. TBP-1 was then inserted in frame into the Pst I-Xba I site of pYVP16 to generate pYVP16-TBP-1.
Transfections and CAT Assays. Each of the reporter plasmids used in this study contains the bacterial chloramphenicol acetyltransferase (CAT) gene fused to different promoters containing between two and six copies of the GAL4 DNAbinding site (GALUAS). GAL4-tk-CAT contains five copies of the GAL4 binding site cloned upstream of the Herpes virus thymidine kinase (TK) promoter in the eukaryotic expression vector pBL2CAT (27) . Plasmid pGMCSAGRE/UAS contains the CAT gene downstream of a mouse mammary tumor virus (MMTV) long terminal repeat (LTR) promoter that has five copies of the GAL4 binding site (28) . pGAL4-HIV(-40)CAT contains two copies of GAL binding site at nucleotide -40 in the HIV LTR. The G6 LTR plasmids contain six copies of the GALUAS sequence present at the nucleotide position indicated within the HIV promoter (29) .
Cell Culture and Transfection. COS-7 cells were maintained in Iscove's modified Dulbecco's medium supplemented with glucose (4.5 mg/ml), 10% fetal calf serum, and gentamicin (50 ,ug/ml; GIBCO). For transient transfection assays, 3 x 105 cells were transfected by the DEAE-dextran procedure (30) . Cells were transfected with 0.5-1.0 ,ug of reporter plasmid and 1-2 jig of the pSVGAL-TBP expression vectors. Cells were harvested 48 h after transfection, and CAT assays were performed as described (31) . For quantitation of CAT activity, a fluorescence diffusion method was used (32) .
Immunofluorescence. COS-7 cells were transfected with plasmid pHATBP-1, pHATBP-7, or pHATBP-1AGKT; 2 days posttransfection they were fixed and permeabilized (33) . Permabilized cells were incubated with monoclonal antibody raised against the influenza HA epitope, incubated with 10 mM glycine in phosphate-buffered saline at 4°C, washed four times with 10 mM glycine in phosphate-buffered saline, and then incubated with a 1:500 dilution of rhodamine isothiocyanate-conjugated goat anti-mouse IgG.
Western Blot Analysis. For Western blot analysis, 2 x 106 COS-7 cells were transfected with the GAL-TBP expression vectors. Proteins were resolved on 10% polyacrylamide gels and blotted onto nitrocellulose membrane filters. Blots were quenched for 2 h at room temperature with block solution (2% gelatin/50 mM Tris, pH 7.5/0.5 M NaCl), incubated at 4°C
with an anti-GAL4 rabbit polyclonal antibody (1:1000) in binding buffer (50 mM Tris, pH 7.5/500 mM NaCl/0.5% gelatin/0.05% Tween 20), and washed four times with washing solution (50 mM Tris, pH 7.5/150 mM NaCl/0.05% Tween 20) . Filters were incubated with 1251-labeled protein A (Amersham) in binding buffer, washed, and autoradiographed with Kodak XAR-5 film.
Dimerization Assays. Growth and manipulation of yeast strains were done according to standard procedures (34).
YJO-Z (GAL4 A, GAL80
A, ura3-52, leu2-3, 112, adel, his3, MEL-I, GAL-J:lacZ) contains an integrated copy of the Escherichia coli p-galactosidase (lacZ) gene under the control of the GAL-1 promoter (35) . YJO-Z was transformed with the indicated expression vectors, and transformants were grown on 3% glycerol/2% lactic acid. 8-Galactosidase activity was determined as described (36) , and units of activity were calculated by the method of Miller (37) .
RESULTS
Isolation of the Full-Length TBP-1 cDNA and a Highly Related Gene. Using biotinylated Tat protein to screen a Agtll cDNA library, we previously described the isolation of the TBP-1 cDNA (17) . The presence of an open reading frame preceding the putative initiator methionine suggested that the full-length clone may not have been obtained. To examine this possibility, the TBP-1 cDNA was used as a probe to rescreen a Agtll library. Of several clones identified, some were identical to the original TBP-1 cDNA. However, at least two cDNAs that contained additional sequence preceding the AUG codon originally identified were obtained (] Fig. 1 ). The new TBP cDNA contains two additional codons encoding methionine residues preceding the codon encoding the methionine first identified. Translation of this cDNA in an in vitro translation lysate suggests that the 5' AUG is efficiently utilized by the translational machinery (data not shown). Thus, this cDNA likely represents the full-length TBP-1 cDNA. The full-length sequence differs from the cDNA originally described by the presence of an additional 35 N-terminal amino acids.
During rescreening of the library, a gene that demonstrates a striking similarity with TBP-1 was also identified (Fig. 1) . The encoded protein, designated TBP-7, is 57% identical and 77% similar to TBP-1 over a 210-amino-acid stretch. As with the other related family members MSS-1 (18) and SUG-1 (20) , the TBP-7 sequence homology does not extend through the amino terminus.
Consistent with the premise that TBP-1 functions with Tat to activate gene expression, its subcellular localization was found to be nuclear (17) . The functional relatedness between TBP-7 and TBP-1 was also examined by identification of its subcellular localization. As observed with TBP-1, the TBP-7 protein showed a predominant nuclear localization (Fig. 2) .
Transcriptional Activity of a GAL-TBP-1 Fusion Protein. To explore the hypothesis that TBP-1 functions with Tat to facilitate transcriptional activation, its ability to interact with DNA was examined. In numerous attempts, using highly purified recombinant TBP-1, we were unable to demonstrate sequence-specific interaction between TBP-1 and DNA. It is possible that TBP-1 does not associate with DNA if it functions through an association with other promoter-bound transcription factors. The requirement for Tat in transactivation might imply that its function is simply to bring TBP-1 to the promoter. To examine the ability of TBP-1 to transactivate in the absence of Tat, a series of protein fusions designed to bring TBP-1 in proximity to the promoter were made. Initially, the entire TBP-1 gene was fused to the DNA-binding domain of the yeast transcriptional activator GAL4 (22) . Cotransfection of pGAL-TBP-1 with either the GALUAs-driven TK or HIV promoter elicited a strong transcriptional activation (Fig. 3A) . Under quantitative conditions, GAL-TBP-1 was found to activate the GAL4-tk-CAT and HIV LTR 4.8-and 8.6-fold, respectively. Moreover, the transcriptional activity was only slightly below that induced by a chimeric GAL4 derivative [GAL4-p65 (24) ] containing the activation domain of NF-KB p6S, a bonafide transcriptional activator (38 deletes residues Gly-Lys-Thr and changes sition 235 to histidine, respectively. These nable to activate either the GALUAs-driven promoter in cotransfection assays (Fig. 4) . TBP/D(285)-A, within the putative helicase nverts the aspartic acid at position 285 to ble to transcriptionally activate the promot--ig. 4). The inability of these plasmids to moters does not reflect lack of protein exexpression of each mutant protein was hat of wild-type GALTBP-1 (Fig. 5) (42) . Neither pYpYVP16-TBP-1 was able to induce lacZ own (Fig. 6A) . However, the combination induced strong transcriptional activity. This iation between the TBP-1 domains bringing ion domain into the proximity ofthe GALUAS (Fig. 6A) . However, deletions at the N terminus did affect dimerization, and indeed the N-terminal 100 amino acids were shown to be sufficient for dimerization [pYGAL-TBP(1-100); Fig. 6A ]. Thus, the N-terminal 100 amino acids confer the dimerization potential of TBP-1. Finally, the ability of pYVP16 TBP-1 to activate lacZ expression in the presence of pYGAL-TBP-7, albeit less than pYGAL-TBP-1, indicates that TBP-1 has a potential to heterodimerize with at least one related family member.
Inspection of the N-terminal 100 amino acids, of both TBP-1 and TBP-7, reveals the presence of a conserved leucine zipper-like structure (Fig. 6B) , a motif known to mediate protein-protein interactions (45) . In accord with previously characterized leucine zipper motifs, the TBP-1 and TBP-7 motifs are composed of a heptad repeat of five hydrophobic amino acids (predominantly leucine) interdigitated with a high density of oppositely charged amino acids. 
